Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20


Fluorescence molecular imaging for identification of high-grade dysplasia in patients with head and neck cancer.

Fakurnejad S, van Keulen S, Nishio N, Engelen M, van den Berg NS, Lu G, Birkeland A, Baik F, Colevas AD, Rosenthal EL, Martin BA.

Oral Oncol. 2019 Aug 12;97:50-55. doi: 10.1016/j.oraloncology.2019.08.008. [Epub ahead of print]


The Sentinel Margin: Intraoperative Ex Vivo Specimen Mapping Using Relative Fluorescence Intensity.

van Keulen S, Nishio N, Birkeland A, Fakurnejad S, Martin B, Forouzanfar T, Cunanan K, Colevas AD, S van den Berg N, Rosenthal E.

Clin Cancer Res. 2019 Aug 1;25(15):4656-4662. doi: 10.1158/1078-0432.CCR-19-0319. Epub 2019 May 29.


Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.

Nishio N, van den Berg NS, van Keulen S, Martin BA, Fakurnejad S, Zhou Q, Lu G, Chirita SU, Kaplan MJ, Divi V, Colevas AD, Rosenthal EL.

Mol Imaging Biol. 2019 May 3. doi: 10.1007/s11307-019-01358-x. [Epub ahead of print]


Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth.

Lamano JB, Lamano JB, Li YD, DiDomenico JD, Choy W, Veliceasa D, Oyon DE, Fakurnejad S, Ampie L, Kesavabhotla K, Kaur R, Kaur G, Biyashev D, Unruh DJ, Horbinski CM, James CD, Parsa AT, Bloch O.

Clin Cancer Res. 2019 Jun 15;25(12):3643-3657. doi: 10.1158/1078-0432.CCR-18-2402. Epub 2019 Mar 1.


The Clinical Application of Fluorescence-Guided Surgery in Head and Neck Cancer.

van Keulen S, Nishio N, Fakurnejad S, Birkeland A, Martin BA, Lu G, Zhou Q, Chirita SU, Forouzanfar T, Colevas AD, van den Berg NS, Rosenthal EL.

J Nucl Med. 2019 Jun;60(6):758-763. doi: 10.2967/jnumed.118.222810. Epub 2019 Feb 7.


Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma.

Clark AJ, Fakurnejad S, Ma Q, Hashizume R.

J Vis Exp. 2016 Jan 15;(107):e53287. doi: 10.3791/53287.


Heat shock protein vaccines against glioblastoma: from bench to bedside.

Ampie L, Choy W, Lamano JB, Fakurnejad S, Bloch O, Parsa AT.

J Neurooncol. 2015 Jul;123(3):441-8. doi: 10.1007/s11060-015-1837-7. Epub 2015 Jun 21. Review.


The likelihood of reaching minimum clinically important difference and substantial clinical benefit at 2 years following a 3-column osteotomy: analysis of 140 patients.

Fakurnejad S, Scheer JK, Lafage V, Smith JS, Deviren V, Hostin R, Mundis GM Jr, Burton DC, Klineberg E, Gupta M, Kebaish K, Shaffrey CI, Bess S, Schwab F, Ames CP; International Spine Study Group.

J Neurosurg Spine. 2015 Sep;23(3):340-8. doi: 10.3171/2014.12.SPINE141031. Epub 2015 Jun 19.


Results of the 2014 SRS Survey on PJK/PJF: A Report on Variation of Select SRS Member Practice Patterns, Treatment Indications, and Opinions on Classification Development.

Scheer JK, Fakurnejad S, Lau D, Daubs MD, Coe JD, Paonessa KJ, LaGrone MO, Amaral RA, Trobisch PD, Lee JH, Fabris-Monterumici D, Anand N, Cree AK, Hart RA, Hey LA, Ames CP; SRS Adult Spinal Deformity Committee.

Spine (Phila Pa 1976). 2015 Jun 1;40(11):829-40. doi: 10.1097/BRS.0000000000000897.


Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells.

Safaee M, Fakurnejad S, Bloch O, Clark AJ, Ivan ME, Sun MZ, Oh T, Phillips JJ, Parsa AT.

PLoS One. 2015 Feb 25;10(2):e0111532. doi: 10.1371/journal.pone.0111532. eCollection 2015.


Evidence-Based Medicine of Traumatic Thoracolumbar Burst Fractures: A Systematic Review of Operative Management across 20 Years.

Scheer JK, Bakhsheshian J, Fakurnejad S, Oh T, Dahdaleh NS, Smith ZA.

Global Spine J. 2015 Feb;5(1):73-82. doi: 10.1055/s-0034-1396047. Epub 2014 Nov 24. Review.


Vaccine therapies in malignant glioma.

Oh T, Sayegh ET, Fakurnejad S, Oyon D, Lamano JB, DiDomenico JD, Bloch O, Parsa AT.

Curr Neurol Neurosci Rep. 2015 Jan;15(1):508. doi: 10.1007/s11910-014-0508-y. Review.


PI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma.

Oh T, Ivan ME, Sun MZ, Safaee M, Fakurnejad S, Clark AJ, Sayegh ET, Bloch O, Parsa AT.

Immunotherapy. 2014;6(6):737-53. doi: 10.2217/imt.14.35. Review.


Principles of surgery for malignant astrocytomas.

Sayegh ET, Oh T, Fakurnejad S, Oyon DE, Bloch O, Parsa AT.

Semin Oncol. 2014 Aug;41(4):523-531. doi: 10.1053/j.seminoncol.2014.06.011. Epub 2014 Jun 30. Review.


Anticonvulsant prophylaxis for brain tumor surgery: determining the current best available evidence.

Sayegh ET, Fakurnejad S, Oh T, Bloch O, Parsa AT.

J Neurosurg. 2014 Nov;121(5):1139-47. doi: 10.3171/2014.7.JNS132829. Epub 2014 Aug 29. Review.


Vaccine therapies for patients with glioblastoma.

Sayegh ET, Oh T, Fakurnejad S, Bloch O, Parsa AT.

J Neurooncol. 2014 Sep;119(3):531-46. doi: 10.1007/s11060-014-1502-6. Epub 2014 Aug 28. Review.


Minimally invasive spinal surgery for the treatment of traumatic thoracolumbar burst fractures.

Oh T, Scheer JK, Fakurnejad S, Dahdaleh NS, Smith ZA.

J Clin Neurosci. 2015 Jan;22(1):42-7. doi: 10.1016/j.jocn.2014.05.030. Epub 2014 Aug 21. Review.


Evidence-based management of traumatic thoracolumbar burst fractures: a systematic review of nonoperative management.

Bakhsheshian J, Dahdaleh NS, Fakurnejad S, Scheer JK, Smith ZA.

Neurosurg Focus. 2014;37(1):E1. doi: 10.3171/2014.4.FOCUS14159. Review.


Biomechanics of thoracolumbar burst fractures: methods of induction and treatments.

Fakurnejad S, Scheer JK, Patwardhan AG, Havey RM, Voronov LI, Smith ZA.

J Clin Neurosci. 2014 Dec;21(12):2059-64. doi: 10.1016/j.jocn.2014.05.002. Epub 2014 Jun 25. Review.


Immunocompetent murine models for the study of glioblastoma immunotherapy.

Oh T, Fakurnejad S, Sayegh ET, Clark AJ, Ivan ME, Sun MZ, Safaee M, Bloch O, James CD, Parsa AT.

J Transl Med. 2014 Apr 29;12:107. doi: 10.1186/1479-5876-12-107. Review.

Supplemental Content

Loading ...
Support Center